SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001176256-08-000473
Filing Date
2008-04-10
Accepted
2008-04-10 16:33:47
Documents
1
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 6228
  Complete submission text file 0001176256-08-000473.txt   7860
Mailing Address
Business Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
ANGIOTECH PHARMACEUTICALS INC (Issuer) CIK: 0001096481 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
Business Address 604-221-7676
Walker Jeffrey Paul (Reporting) CIK: 0001432061 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-30334 | Film No.: 08750318